Literature DB >> 23941673

Serotype-specific anti-Dengue virus NS1 mouse antibodies cross-react with prM and are potentially involved in virus production.

Promsin Masrinoul1, Magot Diata Omokoko, Sabar Pambudi, Kazuyoshi Ikuta, Takeshi Kurosu.   

Abstract

Dengue virus (DENV) infection induces a strong B-cell immune response against the viral nonstructural protein 1 (NS1). Anti-NS1 antibodies (Abs) may affect virus production because they coexist with the virus in the patients' blood. The present study examined whether ten mouse monoclonal antibodies (MAbs) raised against NS1 affected production of the DENV-2. Three MAbs, 4C2, 4G11, and 4E5, showed weak neutralizing activity in a focus reduction assay. In addition, two serotype-specific MAbs, 4C2 and 4G11, protected suckling mice from lethal infection with DENV-2. An immunoprecipitation assay with DENV-2 showed that these MAbs, which were specific for the NS1 of DENV-4 and DENV-1, cross-reacted with the DENV-2 pre-membrane (prM) protein, but not with DENV-2 NS1. Interestingly, high concentrations of MAb 4G11 showed antibody-dependent enhancement of DENV-2 infection in human monocyte THP-1 cells. Taken together, these observations suggest that serotype-specific anti-NS1 MAbs are potentially involved in virus production.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23941673     DOI: 10.1089/vim.2012.0102

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  3 in total

1.  A highly conserved region between amino acids 221 and 266 of dengue virus non-structural protein 1 is a major epitope region in infected patients.

Authors:  Magot Diata Omokoko; Sabar Pambudi; Supranee Phanthanawiboon; Promsin Masrinoul; Chayanee Setthapramote; Tadahiro Sasaki; Motoki Kuhara; Pongrama Ramasoota; Akifumi Yamashita; Itaru Hirai; Kazuyoshi Ikuta; Takeshi Kurosu
Journal:  Am J Trop Med Hyg       Date:  2014-04-28       Impact factor: 2.345

2.  Neutralizing activities of human immunoglobulin derived from donors in Japan against mosquito-borne flaviviruses, Japanese encephalitis virus, West Nile virus, and dengue virus.

Authors:  Mikihiro Yunoki; Takeshi Kurosu; Ritsuko Kubota Koketsu; Kazuo Takahashi; Yoshinobu Okuno; Kazuyoshi Ikuta
Journal:  Biologics       Date:  2016-07-07

3.  Replacement of pr gene with Japanese encephalitis virus pr using reverse genetics reduces antibody-dependent enhancement of dengue virus 2 infection.

Authors:  Ying Wang; Lulu Si; Yayan Luo; Xiaolan Guo; Junmei Zhou; Danyun Fang; Huijun Yan; Gucheng Zeng; Lifang Jiang
Journal:  Appl Microbiol Biotechnol       Date:  2015-07-29       Impact factor: 4.813

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.